In the present study, we demonstrated that the levels of p-JNK, p-p38, p-ERK were dramatically increased following EM-2 treatment, and pretreatment with SB203580 and SP600125 significantly attenuated the increase of p-p38 and p-JNK expression in both LC and BC cells. Here, MAPK8 is linked to breast cancer.